Hubei Guangji Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 339.55 million compared to CNY 375.87 million a year ago. Revenue was CNY 343.91 million compared to CNY 376.02 million a year ago.

Net loss was CNY 25.8 million compared to net income of CNY 24.7 million a year ago. Basic loss per share from continuing operations was CNY 0.0729 compared to basic earnings per share from continuing operations of CNY 0.0703 a year ago. Diluted loss per share from continuing operations was CNY 0.0729.